126 related articles for article (PubMed ID: 12176425)
1. Synergistic effect of high-dose mizoribine and low-dose tacrolimus on renal allograft survival in nonhuman primates.
Tanabe K; Tokumoto T; Shimmura H; Toda F; Ishida H; Omoto K; Toma H
Transplant Proc; 2002 Aug; 34(5):1428. PubMed ID: 12176425
[No Abstract] [Full Text] [Related]
2. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan.
Akiyama T; Okazaki H; Takahashi K; Hasegawa A; Tanabe K; Uchida K; Takahara S; Toma H
Transplant Proc; 2005 Mar; 37(2):843-5. PubMed ID: 15848551
[No Abstract] [Full Text] [Related]
3. Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents.
Zhu Y; Suzuki T; Subbotin VM; Ishizaki N; Jin MB; Urakami A; Shimamura T; Starzl TE; Todo S
Transplant Proc; 1997; 29(1-2):308-9. PubMed ID: 9123011
[No Abstract] [Full Text] [Related]
4. Synergistically enhanced immunosuppressive effect by combined use of cyclosporine and mizoribine.
Amemiya H; Suzuki S; Watanabe H; Hayashi R; Niiya S
Transplant Proc; 1989 Feb; 21(1 Pt 1):956-8. PubMed ID: 2650298
[No Abstract] [Full Text] [Related]
5. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
[No Abstract] [Full Text] [Related]
6. Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE
Transplant Proc; 1995 Feb; 27(1):364-5. PubMed ID: 7533411
[No Abstract] [Full Text] [Related]
7. Involvement of clonal deletion in immunotolerance induction: tests of Tacrolimus administration in rat renal transplantation.
Hayakawa K; Hata M; Yanaihara H; Ohashi M; Ishikawa H; Tazaki H
Transplant Proc; 1994 Aug; 26(4):1863-5. PubMed ID: 7520608
[No Abstract] [Full Text] [Related]
8. Immunosuppressive effects of bactobolamine in vitro and in vivo.
Tomikawa S; Beck Y; Watanabe K; Kikuchi K; Ito S; Ando Y; Ichikawa N; Meigata K; Nomura Y; Degawa H; Nagao T; Uchida H
Transplant Proc; 1996 Apr; 28(2):1049-51. PubMed ID: 8623223
[No Abstract] [Full Text] [Related]
9. Effect of Bredinin on cellular and humoral immune responses and on canine kidney allograft survival.
Okubo M; Kamata K; Yokota K; Uchida H; Masaki Y; Ishigamori E; Kato M; Aso K; Kashiwagi N
Transplant Proc; 1980 Sep; 12(3):515-9. PubMed ID: 6452727
[No Abstract] [Full Text] [Related]
10. Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates.
Ma A; Qi S; Xu D; Daloze P; Chen H
Transplant Proc; 2005; 37(1):150-4. PubMed ID: 15808578
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
Delmonico FL; Knowles RW; Colvin RB; Cavender DE; Kawai T; Bedle M; Stroka D; Preffer FI; Haug C; Cosimi AB
Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
[No Abstract] [Full Text] [Related]
12. Effect of local immunosuppressive therapy with FK 506 on renal allograft survival in the mongrel dog.
Yoshimura N; Hamashima T; Nakamura K; Sudo Y; Yura H; Oka T
Transplant Proc; 1998 Nov; 30(7):3110-1. PubMed ID: 9838372
[No Abstract] [Full Text] [Related]
13. Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.
Borie DC; Changelian PS; Larson MJ; Si MS; Paniagua R; Higgins JP; Holm B; Campbell A; Lau M; Zhang S; Flores MG; Rousvoal G; Hawkins J; Ball DA; Kudlacz EM; Brissette WH; Elliott EA; Reitz BA; Morris RE
Transplantation; 2005 Apr; 79(7):791-801. PubMed ID: 15818321
[TBL] [Abstract][Full Text] [Related]
14. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
Kokado Y; Takahara S; Kyo M; Ichimaru N; Toki K; Wang JD; Okuyama A
Transplant Proc; 1999; 31(1-2):1151-4. PubMed ID: 10083515
[No Abstract] [Full Text] [Related]
15. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine.
Sato K; Yokota K; Matsui T; Imai K; Takishima T; Nakayama Y; Osakabe T; Yoshida M; Mieno H; Omiya H
Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440
[No Abstract] [Full Text] [Related]
16. Potent CD8+ CTLs detected in anti-CD4 (OKT4A) MAb immunosuppressed cynomolgus recipients with prolonged allograft survival.
Wee S; Kawai T; Knowles R; Colvin R; Cosimi AB
Transplant Proc; 1993 Feb; 25(1 Pt 1):794-5. PubMed ID: 8438484
[No Abstract] [Full Text] [Related]
17. Clinical experience of FK 506 for renal allograft transplantation.
Kitamura M; Hiraga S; Kobayashi D; Kakuta T; Fukuuchi F; Hida M; Satoh T
Transplant Proc; 1994 Aug; 26(4):1924-6. PubMed ID: 7520611
[No Abstract] [Full Text] [Related]
18. Preclinical study of a recombinant soluble tumor necrosis factor receptor: effect on immune response of renal allograft recipients.
Wee S; Boskovic S; Eason JD; Widmer MB; Benedict Cosimi A
Transplant Proc; 1995 Feb; 27(1):411-2. PubMed ID: 7879042
[No Abstract] [Full Text] [Related]
19. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
Lye WC
Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
[No Abstract] [Full Text] [Related]
20. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models.
Hoshino Y; Yanagawa Y; Ohtsuki M; Nakayama S; Hashimoto T; Chiba K
Transplant Proc; 1999; 31(1-2):1224-6. PubMed ID: 10083547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
